TTrialPathMatch Me to Trials
← Back to trials
RecruitingHIV InfectionMenopause

Menopausal HT for Women Living With HIV (HoT)

Eligible age

40–60 yrs

Accepts

Women

Locations

14 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Women living with HIV have been shown to experience more frequent and severe hot flashes and night sweats (collectively known as vasomotor symptoms) as compared to women living without HIV. This correlates with disturbed sleep, increased depressive symptoms, increased anxiety, worse mental function, interference with activities of daily living including work, and worse overall quality of life. Hormone therapy is considered to be the most effective therapy for hot flashes and night sweats and the most appropriate choice to prevent bone loss at the time of menopause for women without HIV. However, the usefulness of hormone therapy has not been specifically studied in women living with HIV. This trial is being done to see if: * There is evidence to support the use of hormone therapy (estradiol with or without progesterone) for the treatment of hot flashes and night sweats in women living with HIV * Hormone therapy improves mental function, mood, sleep, quality of life, bone health, heart health, and inflammation in women living with HIV * Hormone therapy is safe and tolerable for women living with HIV

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Where it's recruiting

Alabama

Birmingham

California

Los Angeles · San Diego · San Francisco · Torrance

Colorado

Aurora

Georgia

Atlanta

Illinois

Chicago

Maryland

Baltimore

Missouri

St Louis

New York

New York

North Carolina

Chapel Hill · Greensboro

Ohio

Cincinnati · Cleveland · Columbus

Source: ClinicalTrials.gov · NCT06856174 · last updated 2026-05-22

Menopausal HT for Women Living With HIV (HoT) · TrialPath